Editorial Comment: FDG PET/CT Has the Edge Over Whole-Body MRI in the Evaluation of Multiple Myeloma Treatment Response, For Now. Wu F. AJR Am J Roentgenol 2021 Nov 10. doi: 10.2214/AJR.21.27066.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wu F. Editorial Comment: FDG PET/CT Has the Edge Over Whole-Body MRI in the Evaluation of Multiple Myeloma Treatment Response, For Now. AJR Am J Roentgenol 2021 Nov 10. doi: 10.2214/AJR.21.27066.
PMID: 34755527